In Brief: ISG Technologies
This article was originally published in The Gray Sheet
Executive Summary
ISG Technologies: Receives 510(k) clearance from FDA for use of its Viewing Wand image-guided surgical system in spine applications. The Mississaugu, Ontario firm says it can now market the system for use "on patients who require decompressive or reconstructive surgery of the spine, or who have imaged lesions or malformations in the spine." The Viewing Wand received FDA clearance in 1994 for neurosurgical procedures in the head and neck...
You may also be interested in...
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.
Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative
Cidara conferred global rights to its novel antifungal to marketing partner, Mundipharma, while reacquiring a flu prophylaxis it licensed to J&J in 2021 and gaining $240m in new funding to back development.